Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hims & Hers Health's Beginning Cash Position for the quarter that ended in Mar. 2026 was MXN4,123 Mil.
Hims & Hers Health's quarterly Beginning Cash Position
declined
from Sep. 2025 (MXN20,636 Mil) to Dec. 2025 (MXN6,226 Mil) and
declined
from Dec. 2025 (MXN6,226 Mil) to Mar. 2026 (MXN4,123 Mil).
Hims & Hers Health's annual Beginning Cash Position
increased
from Dec. 2023 (MXN808 Mil) to Dec. 2024 (MXN2,034 Mil) and
increased
from Dec. 2024 (MXN2,034 Mil) to Dec. 2025 (MXN3,987 Mil).
Hims & Hers Health Beginning Cash Position Related Terms
Hims & Hers Health Beginning Cash Position Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's Beginning Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Beginning Cash Position of MXN4,123 Mil mean?
Hims & Hers Health (MEX:HIMS) has a Beginning Cash Position of MXN4,123 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Beginning Cash Position too high?
Hims & Hers Health's current Beginning Cash Position is MXN4,123 Mil. Overall, Hims & Hers Health has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Beginning Cash Position compare to LNTH and LQDA?
Hims & Hers Health's Beginning Cash Position of MXN4,123 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Beginning Cash Position is MXN4,123 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (MEX:HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN693.06, compared to a current price of MXN565.00 — trading 18.5% below its estimated fair value. The current Beginning Cash Position is MXN4,123 Mil. Hims & Hers Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Hims & Hers Health (MEX:HIMS), the current Beginning Cash Position is MXN4,123 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (MEX:HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of MXN565.00 is trading 18.5% below its estimated GF Value™ of MXN693.06.
GuruFocus considers Hims & Hers Health to be Modestly Undervalued.
Key valuation signals for MEX:HIMS:
Beginning Cash Position: MXN4,123 Mil
GF Value™: MXN693.06 vs. price of MXN565.00 (18.5% below fair value)
No single metric tells the full story. See the MEX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
58GF Score
Get the complete analysis for MEX:HIMS
Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:HIMS has been successfully added to your 
